Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose Optimization
Clinical trial NCT03182166 · COMPLETED
Trial details
- NCT number
- NCT03182166
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-21
- Primary completion
- 2021-06-25
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.